HIGHLIGHTS
SUMMARY
Generation of a universal influenza virus vaccine with the potential to elicit long-lasting, broadly cross-reactive immune_responses is a necessity for reducing influenza-associated morbidity and mortality. Targeting these antigens in IAV vaccination studies has been relatively successful as these antigens can induce broadly protective immune_responses through antibody Fc-mediated mechanisms and cellular responses in the context of M2 vaccinations, and cellular responses following NP vaccination10-12. HEK 293 T_cells were transfected with B/Col NP- or luciferase-encoding mRNAs and protein production from NP-encoding mRNA was assessed via Western blotting. Nucleoside . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.